Digital Breast Tomosynthesis Market is estimated to increase at a growth rate of 16.8% CAGR over the forecast period from 2024 to 2030.
The Digital Breast Tomosynthesis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (2D/3D Combination Systems, Standalone 3D Systems), By End-user (Hospitals, Diagnostics Centers, Others).
The digital breast tomosynthesis market in 2024 addresses the demand for advanced breast imaging technologies and screening modalities used in breast cancer detection and diagnosis, providing three-dimensional visualization of breast tissue and improved lesion detection compared to conventional mammography. Digital breast tomosynthesis (DBT) systems capture multiple low-dose X-ray images from different angles, reconstructing thin slices of breast tissue to reduce overlapping structures and improve cancer detection sensitivity and specificity. Market dynamics are driven by factors such as the increasing incidence of breast cancer and the demand for early detection and diagnosis, the growing adoption of breast cancer screening guidelines recommending DBT as an adjunct to mammography, and advancements in DBT technology for enhanced image quality and workflow efficiency. Collaboration between medical imaging companies, breast radiologists, and oncologists drives innovation and market growth in digital breast tomosynthesis, supporting improved breast cancer detection rates and patient outcomes in breast healthcare.
A significant trend in the Digital Breast Tomosynthesis market is the shift towards using digital breast tomosynthesis (DBT) for breast cancer screening. DBT, also known as 3D mammography, offers superior imaging capabilities compared to traditional 2D mammography, allowing for clearer visualization of breast tissue and improved detection of abnormalities, including small tumors and lesions. This trend is driven by growing recognition of the limitations of 2D mammography in detecting breast cancer, particularly in women with dense breast tissue, as well as advancements in DBT technology and increased availability of DBT systems. As healthcare providers prioritize more accurate and effective breast cancer screening methods, the adoption of DBT is expected to continue to grow, reshaping the landscape of breast imaging and driving market growth in the Digital Breast Tomosynthesis segment.
A key driver in the Digital Breast Tomosynthesis market is the rising incidence of breast cancer and the emphasis on early detection for improved patient outcomes. Breast cancer is one of the most common cancers among women worldwide, and early detection plays a crucial role in reducing mortality rates and improving survival rates. DBT offers advantages over 2D mammography by reducing false positives, improving cancer detection rates, and providing better visualization of breast tissue, particularly in women with dense breasts. Additionally, guidelines and recommendations from healthcare organizations increasingly support the use of DBT as a primary screening modality for breast cancer. As the demand for more accurate and reliable breast cancer screening methods grows, driven by factors such as aging populations, changing lifestyles, and increased awareness of breast health, the adoption of DBT is expected to rise, fueling market expansion in the Digital Breast Tomosynthesis segment.
An opportunity for growth in the Digital Breast Tomosynthesis market lies in the expansion into adjacent markets and applications. While DBT is primarily used for breast cancer screening, there may be opportunities to explore its utility in other areas of breast imaging and healthcare. For example, DBT could be leveraged for diagnostic purposes, such as characterizing breast lesions, evaluating treatment response, or guiding minimally invasive procedures. Additionally, expanding access to DBT in underserved regions or integrating DBT with other imaging modalities for comprehensive breast imaging solutions presents opportunities for market expansion and increased adoption. By exploring new markets and applications for DBT technology, companies can broaden their market reach, address unmet medical needs, and drive innovation in breast imaging. Embracing opportunities for expansion into adjacent markets and applications presents a compelling avenue for growth and differentiation in the Digital Breast Tomosynthesis market.
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Becton, Dickinson and Company
Canon Inc
F. Hoffmann-La Roche Ltd
FUJIFILM Holdings Corp
General Electric
Hitachi Ltd
Hologic Inc
Koninklijke Philips N.V.
Quest Diagnostics Inc
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
Shimadzu Medical pvt. Ltd
Siemens
Sysmex India Pvt. Ltd
Thermo Fisher Scientific Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Digital Breast Tomosynthesis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Digital Breast Tomosynthesis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Digital Breast Tomosynthesis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Digital Breast Tomosynthesis Market Size Outlook, $ Million, 2021 to 2030
3.2 Digital Breast Tomosynthesis Market Outlook By Type, $ Million, 2021 to 2030
3.3 Digital Breast Tomosynthesis Market Outlook By Product, $ Million, 2021 to 2030
3.4 Digital Breast Tomosynthesis Market Outlook By Application, $ Million, 2021 to 2030
3.5 Digital Breast Tomosynthesis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Digital Breast Tomosynthesis Market Industry
4.2 Key Market Trends in Digital Breast Tomosynthesis Market Industry
4.3 Potential Opportunities in Digital Breast Tomosynthesis Market Industry
4.4 Key Challenges in Digital Breast Tomosynthesis Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Digital Breast Tomosynthesis Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Digital Breast Tomosynthesis Market Outlook By Segments
7.1 Digital Breast Tomosynthesis Market Outlook by Segments
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
8 North America Digital Breast Tomosynthesis Market Analysis And Outlook To 2030
8.1 Introduction to North America Digital Breast Tomosynthesis Markets in 2024
8.2 North America Digital Breast Tomosynthesis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Digital Breast Tomosynthesis Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
9 Europe Digital Breast Tomosynthesis Market Analysis And Outlook To 2030
9.1 Introduction to Europe Digital Breast Tomosynthesis Markets in 2024
9.2 Europe Digital Breast Tomosynthesis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Digital Breast Tomosynthesis Market Size Outlook By Segments, 2021-2030
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
10 Asia Pacific Digital Breast Tomosynthesis Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Digital Breast Tomosynthesis Markets in 2024
10.2 Asia Pacific Digital Breast Tomosynthesis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Digital Breast Tomosynthesis Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
11 South America Digital Breast Tomosynthesis Market Analysis And Outlook To 2030
11.1 Introduction to South America Digital Breast Tomosynthesis Markets in 2024
11.2 South America Digital Breast Tomosynthesis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Digital Breast Tomosynthesis Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
12 Middle East And Africa Digital Breast Tomosynthesis Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Digital Breast Tomosynthesis Markets in 2024
12.2 Middle East and Africa Digital Breast Tomosynthesis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Digital Breast Tomosynthesis Market size Outlook by Segments, 2021-2030
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Becton, Dickinson and Company
Canon Inc
F. Hoffmann-La Roche Ltd
FUJIFILM Holdings Corp
General Electric
Hitachi Ltd
Hologic Inc
Koninklijke Philips N.V.
Quest Diagnostics Inc
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
Shimadzu Medical pvt. Ltd
Siemens
Sysmex India Pvt. Ltd
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
2D/3D Combination Systems
Standalone 3D Systems
By End-user
Hospitals
Diagnostics Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Digital Breast Tomosynthesis Market is one of the lucrative growth markets, poised to register a 16.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Becton, Dickinson and Company, Canon Inc, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, General Electric, Hitachi Ltd, Hologic Inc, Koninklijke Philips N.V., Quest Diagnostics Inc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Shimadzu Medical pvt. Ltd, Siemens, Sysmex India Pvt. Ltd, Thermo Fisher Scientific Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume